Serum level of S100A8/A9 as a biomarker for establishing the diagnosis and severity of community-acquired pneumonia in children
暂无分享,去创建一个
Shihao Zhuang | W. Tuo | Yun Xiang | Qinzhen Cai | Hongming Zhu | Chunhui Yuan | Cong Yao | Si Xie | Jun Wang | F. Han
[1] Donald H. Arnold,et al. Pneumonia Severity in Children: Utility of Procalcitonin in Risk Stratification. , 2021, Hospital pediatrics.
[2] Pingping Wang,et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas , 2021, Cell.
[3] Samir S. Shah,et al. Development and Internal Validation of a Prediction Model to Risk Stratify Children with Suspected Community-Acquired Pneumonia. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] K. Baumstarck,et al. Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia , 2020, Intensive Care Medicine.
[5] W. Wang,et al. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[6] Samir S. Shah,et al. Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia , 2020, Pediatrics.
[7] J. Alcorn,et al. Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia , 2019, Clinical Microbiology Reviews.
[8] S. Karna,et al. Salivary S100 proteins screen periodontitis among Korean adults , 2019, Journal of clinical periodontology.
[9] Jian Ma,et al. S100A8/A9 in Inflammation , 2018, Front. Immunol..
[10] M. Lippman,et al. Targeting RAGE Signaling in Inflammatory Disease. , 2018, Annual review of medicine.
[11] A. Torres,et al. Immunological profiling to assess disease severity and prognosis in community-acquired pneumonia. , 2017, The Lancet. Respiratory medicine.
[12] A. Zarbock,et al. Alarmin S100A8 Activates Alveolar Epithelial Cells in the Context of Acute Lung Injury in a TLR4-Dependent Manner , 2017, Front. Immunol..
[13] R. Hotchkiss,et al. Host-directed therapies for bacterial and viral infections , 2017, Nature Reviews Drug Discovery.
[14] R. Sultana,et al. Risk factors for mortality in children with pneumonia admitted to the pediatric intensive care unit , 2017, Pediatric pulmonology.
[15] S. Esposito,et al. Biomarkers in Pediatric Community-Acquired Pneumonia , 2016, International journal of molecular sciences.
[16] M. Sperandio,et al. S100A8/A9: From basic science to clinical application. , 2016, Pharmacology & therapeutics.
[17] S. Blankson,et al. Myeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4- and TLR2-mediated signal pathways , 2015, Scientific Reports.
[18] R. Gearry,et al. Disease Activity Assessment in IBD: Clinical Indices and Biomarkers Fail to Predict Endoscopic Remission , 2015, Inflammatory bowel diseases.
[19] M. Rebelatto,et al. S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo , 2015, PloS one.
[20] Jamie Perin,et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis , 2015, The Lancet.
[21] Eric P. Skaar,et al. Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia , 2014, Thorax.
[22] N. Hogg,et al. A new protective role for S100A9 in regulation of neutrophil recruitment during invasive pneumococcal pneumonia , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] M. Chimenti,et al. Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways. , 2013, Autoimmunity reviews.
[24] A. Harnden,et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011 , 2011, Thorax.
[25] Igor Rudan,et al. Causes of deaths in children younger than 5 years in China in 2008 , 2010, The Lancet.
[26] M. Boermeester,et al. Expression and role of myeloid-related protein-14 in clinical and experimental sepsis. , 2009, American journal of respiratory and critical care medicine.
[27] G. Steinbach,et al. Inflammatory peritoneal reaction after perforated appendicitis: continuous peritoneal lavage versus non lavage. , 2007, European journal of medical research.
[28] W. Chiang,et al. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community‐acquired pneumonia in 1702 hospitalized children in Singapore , 2007, Respirology.
[29] H. Kido,et al. Myeloid-related protein-8/14 is associated with proinflammatory cytokines in cervical mucus. , 2006, Journal of Reproductive Immunology.
[30] W. Lim,et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.
[31] Z. Bhutta,et al. The remaining challenge of pneumonia: the leading killer of children. , 2011, The Pediatric infectious disease journal.
[32] Samir S. Shah,et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] Igor Rudan,et al. Epidemiology and etiology of childhood pneumonia. , 2008, Bulletin of the World Health Organization.